Profile
Ming-Fu Chiang is currently Director at NeOnc Technologies, Inc. and Director at NeOnc Technologies Holdings, Inc. starting in 2025.
Formerly, Director at NeOnc Technologies Holdings, Inc. in 2025.
Education includes a doctorate from Freie Universität Berlin and an MBA from National Taiwan University.
Alan Chaing active positions
| Companies | Position | Start |
|---|---|---|
NeOnc Technologies, Inc.
NeOnc Technologies, Inc. Pharmaceuticals: MajorHealth Technology Engage in development and commercialization of central nervous system therapeutics | Director/Board Member | - |
Former positions of Alan Chaing
| Companies | Position | End |
|---|
Training of Alan Chaing
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
NeOnc Technologies, Inc.
NeOnc Technologies, Inc. Pharmaceuticals: MajorHealth Technology Engage in development and commercialization of central nervous system therapeutics | Health Technology |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Alan Chaing
















